These results indicated that C0 IGFBP7+ Glioma cells might be at the end of differentiation and have high differentiation ability, and C6 DLL3+ Glioma cells might be at the initial stage of differentiation. This evidence concerns the gene IGFBP7 and central nervous system cancer.